The UAE has become the second country to approve once-daily, oral pill - Lipfendra - to treat adults with elevated low-density lipoprotein (LDL-C) cholesterol, a leading risk factor for cardiovascular disease.
Making the announcement, the Emirates Drug Establishment (EDE) explained that Lipfendra can also treat "certain inherited conditions" as long as it is cleared by a healthcare professional.
It is said to expand treatment options for adults and improve their quality of life.
Patients are advised to maintain a balanced diet and regular physical activity alongside the treatment.
The move is part of efforts by the UAE to authorise innovative medicines and expand treatment options for adults.
H.H. Sheikh Mohammed receives condolences on passing of Sheikh Ahmed
Sheikh Abdullah meets President of Ecuador on UNGA81 sidelines
Dubai Police trains school bus drivers and supervisors on student safety
UAE welcomes US statement on Sudan peace efforts
UAE among global leaders in nuclear security progress
Sharjah approves over AED17.8 million in debt settlement for citizens
Sheikh Abdullah chairs UAE-France-India trilateral meeting at UN
ട്രംപ് വിളിച്ചുചേർത്ത യോഗത്തിൽ ഷെയ്ഖ് അബ്ദുല്ല ബിൻ സായിദ് അൽ നഹ്യാൻ പങ്കെടുത്തു
